Period:
Draw Mode:
| Volume | 35,675 |
|
|||||
| News | - | ||||||
| Day High | 1.9319 | Low High |
|||||
| Day Low | 1.75 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| InspireMD Inc New | NSPR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0718 | -3.88% | 1.7782 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.85 | 1.75 | 1.9319 | 1.7782 | 1.85 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 174 | 35,675 | $ 1.83 | $ 65,156 | - | 0.8064 - 2.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:53:17 | 2 | $ 1.80 | USD |
InspireMD Inc New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 14.86M | 8.36M | 7.87M | $ 1.24M | $ -42.62k | -0.53 | -348.63 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
InspireMD News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NSPR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.66 | 1.9319 | 1.605 | 1.74 | 34,247 | 0.1182 | 7.12% |
| 1 Month | 1.36 | 2.40 | 1.2951 | 1.80 | 218,589 | 0.4182 | 30.75% |
| 3 Months | 1.23 | 2.40 | 0.960801 | 1.69 | 89,461 | 0.5482 | 44.57% |
| 6 Months | 1.21 | 2.40 | 0.84 | 1.56 | 53,926 | 0.5682 | 46.96% |
| 1 Year | 2.17 | 2.40 | 0.8064 | 1.53 | 36,486 | -0.3918 | -18.06% |
| 3 Years | 5.12 | 6.82 | 0.8064 | 4.17 | 127,863 | -3.34 | -65.27% |
| 5 Years | 5.12 | 6.82 | 0.8064 | 4.17 | 127,863 | -3.34 | -65.27% |
InspireMD Description
| InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries. |